86 related articles for article (PubMed ID: 23063651)
1. Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol.
Gopalan A; Yu W; Sanders BG; Kline K
Cancer Lett; 2013 Jan; 328(2):285-96. PubMed ID: 23063651
[TBL] [Abstract][Full Text] [Related]
2. Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP-1 inhibition of Stat3 signaling.
Xiong A; Yu W; Liu Y; Sanders BG; Kline K
Mol Carcinog; 2016 May; 55(5):420-30. PubMed ID: 25648304
[TBL] [Abstract][Full Text] [Related]
3. Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells.
Gopalan A; Yu W; Jiang Q; Jang Y; Sanders BG; Kline K
Mol Nutr Food Res; 2012 Dec; 56(12):1803-11. PubMed ID: 23065795
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
Wali VB; Bachawal SV; Sylvester PW
Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
[TBL] [Abstract][Full Text] [Related]
5. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
Hsieh TC; Wu JM
Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of combined treatment with gamma-tocotrienol and statin on human malignant mesothelioma cells.
Tuerdi G; Ichinomiya S; Sato H; Siddig S; Suwa E; Iwata H; Yano T; Ueno K
Cancer Lett; 2013 Oct; 339(1):116-27. PubMed ID: 23879968
[TBL] [Abstract][Full Text] [Related]
8. Gamma-tocotrienol reverses multidrug resistance of breast cancer cells with a mechanism distinct from that of atorvastatin.
Ding Y; Peng Y; Deng L; Fan J; Huang B
J Steroid Biochem Mol Biol; 2017 Mar; 167():67-77. PubMed ID: 27864002
[TBL] [Abstract][Full Text] [Related]
9. Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells.
Bachawal SV; Wali VB; Sylvester PW
Anticancer Res; 2010 Feb; 30(2):429-37. PubMed ID: 20332450
[TBL] [Abstract][Full Text] [Related]
10. Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.
Ginestier C; Monville F; Wicinski J; Cabaud O; Cervera N; Josselin E; Finetti P; Guille A; Larderet G; Viens P; Sebti S; Bertucci F; Birnbaum D; Charafe-Jauffret E
Stem Cells; 2012 Jul; 30(7):1327-37. PubMed ID: 22605458
[TBL] [Abstract][Full Text] [Related]
11. The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells.
Vitale G; Zappavigna S; Marra M; Dicitore A; Meschini S; Condello M; Arancia G; Castiglioni S; Maroni P; Bendinelli P; Piccoletti R; van Koetsveld PM; Cavagnini F; Budillon A; Abbruzzese A; Hofland LJ; Caraglia M
Biotechnol Adv; 2012; 30(1):169-84. PubMed ID: 21871555
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
Akl MR; Ayoub NM; Sylvester PW
Planta Med; 2012 Nov; 78(16):1731-9. PubMed ID: 22987298
[TBL] [Abstract][Full Text] [Related]
13. Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment.
Wali VB; Bachawal SV; Sylvester PW
Lipids; 2009 Oct; 44(10):925-34. PubMed ID: 19777282
[TBL] [Abstract][Full Text] [Related]
14. gamma-Tocotrienol controls proliferation, modulates expression of cell cycle regulatory proteins and up-regulates quinone reductase NQO2 in MCF-7 breast cancer cells.
Hsieh TC; Elangovan S; Wu JM
Anticancer Res; 2010 Jul; 30(7):2869-74. PubMed ID: 20683025
[TBL] [Abstract][Full Text] [Related]
15. Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population.
Luk SU; Yap WN; Chiu YT; Lee DT; Ma S; Lee TK; Vasireddy RS; Wong YC; Ching YP; Nelson C; Yap YL; Ling MT
Int J Cancer; 2011 May; 128(9):2182-91. PubMed ID: 20617516
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells.
Xiong A; Yu W; Tiwary R; Sanders BG; Kline K
Mol Nutr Food Res; 2012 Jun; 56(6):923-34. PubMed ID: 22707267
[TBL] [Abstract][Full Text] [Related]
17. Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.
Göbel A; Browne AJ; Thiele S; Rauner M; Hofbauer LC; Rachner TD
Breast Cancer Res Treat; 2015 Dec; 154(3):623-31. PubMed ID: 26515701
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
19. In vivo evidence of gamma-tocotrienol as a chemosensitizer in the treatment of hormone-refractory prostate cancer.
Yap WN; Zaiden N; Luk SY; Lee DT; Ling MT; Wong YC; Yap YL
Pharmacology; 2010; 85(4):248-58. PubMed ID: 20375535
[TBL] [Abstract][Full Text] [Related]
20. Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells.
Yap WN; Zaiden N; Tan YL; Ngoh CP; Zhang XW; Wong YC; Ling MT; Yap YL
Cancer Lett; 2010 May; 291(2):187-99. PubMed ID: 19926394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]